Financhill
Buy
62

MIRM Quote, Financials, Valuation and Earnings

Last price:
$100.56
Seasonality move :
1.91%
Day range:
$97.49 - $101.08
52-week range:
$36.88 - $105.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.84x
P/B ratio:
17.68x
Volume:
588.7K
Avg. volume:
770.1K
1-year change:
96.12%
Market cap:
$5.2B
Revenue:
$336.9M
EPS (TTM):
-$0.86

Earnings Data

Next earnings date for MIRM
Feb 25
2026
Most recent earnings per share
$0.05
Beat by $0.21
(Nov 4/2025)
Consensus Estimate
-$0.16
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $149.3M -- -- $0.04 --
02/25/2026 Q4 $140.9M -- -- $0.04 --
11/04/2025 Q3 $130.5M $133M $0.05 -$0.16 $0.21
08/06/2025 Q2 $108.1M $127.8M -$0.12 -$0.33 $0.22
05/07/2025 Q1 $98.4M $111.6M -$0.30 -$0.27 -$0.03
02/26/2025 Q4 $96.6M $99.4M -$0.49 -$0.25 -$0.25
11/12/2024 Q3 $82M $90.4M -$0.30 -$0.45 $0.15
08/07/2024 Q2 $75.1M $77.9M -$0.52 -$0.46 -$0.06
05/08/2024 Q1 $70.2M $69.2M -$0.54 -$0.30 -$0.23
02/28/2024 Q4 $67.9M $69.6M -$0.71 -$0.22 -$0.48
11/02/2023 Q3 -- $47.7M -$0.57 -- --
08/03/2023 Q2 -- $37.5M -$1.94 -- --
05/04/2023 Q1 -- $31.6M -$0.80 -- --
03/08/2023 Q4 -- $27.9M -$0.99 -- --
11/09/2022 Q3 -- $18.8M -$1.02 -- --
08/04/2022 Q2 -- $17.5M -$0.84 -- --
05/05/2022 Q1 -- $12.9M -$1.17 -- --
03/09/2022 Q4 -- $3.1M $1.88 -- --
11/15/2021 Q3 -- $5M -$1.55 -- --
08/05/2021 Q2 -- $11M -$1.45 -- --
05/06/2021 Q1 -- -- -$1.68 -- --
03/09/2021 Q4 -- -- -$1.43 -- --
11/12/2020 Q3 -- -- -$0.86 -- --
08/06/2020 Q2 -- -- -$0.93 -- --
05/07/2020 Q1 -- -- -$0.86 -- --
03/12/2020 Q4 -- -- -$0.78 -- --
11/06/2019 Q3 -- -- -$0.66 -- --
08/28/2019 Q2 -- -- -$0.59 -- --
03/31/2019 Q1 -- -- -$0.26 -- --

Mirum Pharmaceuticals, Inc. Earnings Questions

  • How Much did Mirum Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Mirum Pharmaceuticals, Inc. reported $133M worth of top line sales in its most recent quarter.

  • Did Mirum Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Mirum Pharmaceuticals, Inc. announced earnings per share of $0.05 which represents a beat of analyst forecast a -$0.16 per share.

  • Is Mirum Pharmaceuticals, Inc. Profitable?

    Mirum Pharmaceuticals, Inc. reported $107.4M that represents $1.88 per share over the last quarter.

  • What is the Analyst Consensus for Mirum Pharmaceuticals, Inc. EPS Next Year?

    Mirum Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.85 per share to -$0.27 per share next year representing a decrease of -90.45%.

  • When is Mirum Pharmaceuticals, Inc.'s Earnings Date?

    Mirum Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock